Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 38RL9AE51Q

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Interferon-alpha/beta receptor alpha chain antagonist PubMed PubMed
Primary Target
interferon α/β receptor 1

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Erythematosus, Systemic 4 D008180 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Lupus Nephritis 2 D008181 ClinicalTrials
Scleroderma, Localized 1 D012594 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1326232-46-5
ChEMBL CHEMBL2364653
FDA SRS 38RL9AE51Q
Guide to Pharmacology 8258